期刊文献+

肾康丸对2型糖尿病大鼠肾脏TRAIL系统表达的影响 被引量:3

Effects of Shenkangwan on the expression of tumor necrosis factor-related apoptosis-inducing ligand system in type 2 diabetic rats
下载PDF
导出
摘要 目的:观察肾康丸治疗对2型糖尿病(T2DM)大鼠肾组织TRAIL系统表达的影响,探讨其肾脏保护作用机制。方法:建立T2DM大鼠模型。成模后将大鼠随机分为2组:模型对照组(DM)、肾康丸组(DS);另设正常对照组(C)。分组干预,全自动生化仪检测高密度脂蛋白胆固醇(FBG)、总胆固醇(TC)及空腹血糖(FBG)(HDL-C);ELISA法检测尿微量白蛋白α1-MG(Uα1-MG)、24 h尿微量白蛋白(24h UmAlb),Q-RT-PCR法检测TRAIL、DR4、DcR2mRNA在肾组织表达,HE染色法观察大鼠肾组织病理变化。结果:随着实验时间的延长,DM组FBG及TC升高,HDL-C降低,而DS组FBG及TC降低,HDL-C升高;与C组相比,第4周、第8周DM组大鼠Uα1-MG、24h UmAlb均显著升高(P<0.01,P<0.01),肾组织DcR2 mRNA表达显著增强(P<0.01);而TRAIL、DR4 mRNA表达显著减弱(P<0.01),并且DM组大鼠出现了肾脏组织病理损害;DS组各指标均呈相反改变,肾脏病理损害减轻。结论:肾康丸通过影响TRAIL系统的表达,对T2DM大鼠具有显著的肾保护作用。 Aim:To explore the effect of Shenkangwan on the expression of tumor necrosis factor-relat-ed apoptosis-inducing ligand system(TRAIL)in the kidneys of type 2 diabetes rats.Methods:The rat models of type 2 diabetes were randomly divided into diabetic model group (DM)and Shenkangwan treat-ment group (DS),with the rats fed with normal chow as the control group (C).After treatment,The FBG,TC and HDL-C were detected by automatic biochemical analyzer.The levels of urine α1-MG (Uα1-MG)and 24 hour urine mAlb (24h UmAlb)were detected by ELISA,and the expressions of TRAIL,death receptor 4 (DR4 )and decoy receptor 2 (DcR2 )protein and mRNA in the kidney were measured by immune histochemistry and quantitative real-time PCR(Q-RT-PCR),Then we investigated their renal pathological change under optical microscope with the coloration method of Hematoxylin and E-osin(HE).Results:The levels of FBG and TC increased while HDL-C reduced in the DMgroup,these changes were all reversed after treatment with Shenkangwan.Compared with C group,the levels of Uα1-MG,24h UmAlb,and the renal expressions of DcR2 protein and mRNA increased significantly (P 〈0.01 );however,the expressions of TRAIL and DR4 protein and mRNA(P〈0.01 )reduced significantly and came forth about the renal pathological lesion in the DM group.These changes were all reversed and the renal pathological lesion was mitigated after treatment with Shenkangwan.Conclusion:Shenkangwan have significant renal protection on T2DMrats,its mechanisms may be the effects on expression of TRAIL system.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2013年第6期621-625,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家自然科学基金青年项目(81001674) 广东省医学科学技术研究基金(A2010669)
关键词 肾康丸 2型糖尿病 糖尿病肾病 TRAIL系统 Shenkangwan Type 2 diabetes diabetic nephropathy TRAIL system
  • 相关文献

参考文献10

  • 1AMITABH D, RITUPARNA M,TEJASWI K, et al. Noveldrug treatment for diabetic nephropathy [ J ]. Hong KongNephrol,2011,13(1) :19 -26.
  • 2CHOW F, OZOLS E,NIKOLIC-PATERSON D J,et al.Macrophages in mouse type 2 diabetic nephropathy : corre-lation with diabetic state and progressive renal injury [J].Kidney Int,2004,65( 1) : 116 - 128.
  • 3PFLEIDERER S,ZIRNMERHACK L B’KIRME K,et al.Renal proximal and distaltublar function is attenuated indiabetes mellitus type as derermined by renal excretion ofalpha microglobin and Tamm Horsfall protein [ J ]. ClinInvest Med,1993,71 (12) :972 -977.
  • 4LI P B, LIN W L, WANG Y G, et al. Antidiabetic ac-tivities of oligosaccharides of Ophiopogonis japonicus inexperimenttal type 2 diabetic rats[ J]. International Jour-nal of Biological Macromolecules, 2012, 51 ( 5 ) : 749 -755.
  • 5WU D, WEN W, QI C L,et al. Ameliorative effect of ber-berine on renal damage in rats with diabetes induced byhigh-fat diet and streptozotocin[ J]. Phytom edicine,2012,19(8-9); 712-718.
  • 6SPIERINGS D C,DE VRIES E G,VELLENGA E,et al.Tissue distribution of the death ligalld TRAIL and its re-ceptors [J ]. Histochem Cytochem,2004, 52 ( 6 ) : 821 -831.
  • 7陈兵,柳刚,张燕,关广聚,侯香华,李学刚,王海萍.肿瘤坏死因子相关的凋亡诱导配体系统和核因子KB在糖尿病大鼠肾脏中的表达[J].中华肾脏病杂志,2007,23(11):734-739. 被引量:3
  • 8KIM Joo-Young, LEE Ju-Yeon, KIM Dong-Gun, et al.TRADD is critical for resistance to TRAIL-induced celldeath through NF-kB activation [ J ]. FEBS Letters, 2011,585(14) :2144-2150.
  • 9Maria-Dolores,Sanchez-Nino, ANA B S,et al. The MIFreceptor CD74 in diabetic podocyte injury [J]. J Am SocNephrol,2009, 20:353 -362.
  • 10杨志霞,林谦,马利,孙中成,李斐斐,李根茂,葛冬宇.黄芪多糖丹参酮对慢性心衰大鼠MIF表达的调控作用[J].中国药理学通报,2011,27(9):1214-1217. 被引量:17

二级参考文献10

  • 1Fiona C. KIMBERLEY,Gavin R. SCREATON.Following a TRAIL: Update on a ligand and its five receptors[J].Cell Research,2004,14(5):359-372. 被引量:27
  • 2张灼,陈立新,宋崇顺,秦腊梅,任映,郭菁,寇嘉靓.黄芪多糖对大鼠心肌缺血-再灌注损伤后的保护作用[J].中国中医药信息杂志,2007,14(2):33-34. 被引量:34
  • 3Zernecke A,Bernhage J,Weber C.Macrophage migration inhibitoryfactor in cardiovascular disease. Circulation . 2008
  • 4Meyer T,Stanske B,Kochen M M,et al.Elevated serum levels ofinterleukin-10 and tumor necrosis factor-αare both associated withvital exhaustion in patints with cardiovascular risk factors. Psychosomatics . 2010
  • 5Wu C K,Lee J K,Chiang F Tet al.Plasma levels of tumor necro-sis factor-αand interleukin-6 are associated with diastolic heartfailure through downregulation of sarcoplasmic reticulum Ca2+-ATP-ase. Critical Care Medicine . 2011
  • 6Guggilam A,Cardinale J P,Mariappan N,et al.Central TNF inhi-bition results in attenuatd neurohumoral excitation in heart failure:a role for superoxide and nitric oxide. Basic Research In Cardiology . 2011
  • 7Deten A,Holzl A,Leicht M,et al.Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. Journal of Molecular and Cellular Cardiology . 2001
  • 8Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation . 2005
  • 9王蕾,张世杰,王海鹏,邹操,蒋彬,赵彩明,刘志华,蒋文平.阿托伐他汀对兔舒张性心力衰竭模型心室重构的影响[J].中国循环杂志,2010,25(3):223-226. 被引量:16
  • 10黄涌,阮经文,杨春涛,杨战利,莫利球,王秀玉,董小变,廖新学,冯鉴强.依达拉奉保护H9c2心肌细胞对抗异丙肾上腺素诱导的氧化应激及内质网应激反应[J].中国药理学通报,2011,27(3):410-415. 被引量:11

共引文献18

同被引文献60

  • 1刘燕霞,史国辉.肾康注射液对腺嘌呤致肾间质纤维化的预防机制[J].中国医学前沿杂志(电子版),2012,4(9):47-51. 被引量:4
  • 2Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis [ J 1 .Immunity,1995,3 ( 6 ) :673-682.
  • 3Sun EW,Shi YF.Apoptosis:the quiet death silences the immune system I J ] .Pharmacol Ther,2001,92 ( 2-3 ) : 135-145.
  • 4Marsters SA,Sheridan JP,Pitti RM,et al.A novel receptor for Apo2L/TRAIL contains a truncated death domain [ J I. Curr Bio1,1997,7 (12) :1003-1006.
  • 5MacFarlane M,Ahmad M,Srinivasula SM,et al.Identifi- cation and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL [ J 1 .J Biol Chem, 1997,272 (41) :25417-25420.
  • 6Degli-Esposti MA,Smolak PJ,Walczak H,et al.Cloning and characterization of TRAIL-R3,a novel member of the emerging TRAIL receptor family [ J ] .J Exp Med,1997,186 ( 7 ) :1165-1170.
  • 7Walczak H,Degli-Esposti MA,Johnson RS,et al.TRAIL- R2:a novel apoptosis-mediating receptor for TRAIL[ J ]. EMBO J,1997,16 ( 17 ) :5386-5397.
  • 8Kim Y,Seol DW.TRAIL,a mighty apoptosis inducer[J]. Mol Cells,2003,15 ( 3 ) :283-293.
  • 9Oldenhuis CN,Stegehuis JH,Walenkamp AM,et al.Tar- geting TRAIL death receptors I J ] .Curr Opin Pharma- col,2008,8 ( 4 ) :433-439.
  • 10Hilliard B,Wilmen A,Seidel C,et al.Roles of TNF-re- lated apoptosis-inducing ligand in experimental auto-immune encephalomyelitis [ J ] .J Immunol,2001,166 ( 2 ) :1314-1319.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部